Stephanie Maley (of Factotum) has joined the Executive Team of Stablepharma

As Stablepharma continues to expand the teams in both London and Madrid, CEO & Executive Director, Ozgur Tuncer was delighted to announce that Stephanie Maley (of Factotum) has joined the executive team of Stablepharma in the role of Chief People Officer. Stephanie started her career in the finance industry and then moved into HR Consultancy. […]

Read More

Dr Kenny Simmen joins the Stablepharma Advisory Board

Stablepharma is delighted to welcome Dr Kenny Simmen to the Advisory Board, who brings over 30 years pharmaceutical expertise in R&D with a successful track record in drug discovery and external innovation. Dr Simmen will work closely with the science and commercial teams to support further R&D deals and evaluate suitable vaccine candidates that will […]

Read More

Innovate UK awards Stablepharma a second grant to advance fridge-free vaccines

Stablepharma Ltd, the Fridge-free Vaccine Company, has been awarded a second Innovate UK Grant, in partnership with University Hospital Southampton NHS Foundation Trust, as it commences a bridge-funding round in Q4 2023. This joint Innovate UK grant will advance the clinical development of Stablepharma’s lead candidate, SPVX02, a fridge-free vaccine for the prevention of Tetanus […]

Read More

Wealth Briefing reports on new Advisory Board Members Joining Stablepharma Ltd

Dr Ceri Morgan and Richard Lane join the Stablepharma Ltd Advisory Board at a time of growth and investment. Stablepharma Ltd is delighted to announce two new members who will join the Advisory Board with immediate effect – Richard Lane, an experienced corporate lawyer and Dr Ceri Morgan, Senior Advisor & NED, specialising in capital […]

Read More

Stablepharma sign a second exclusive supply agreement to develop a fridge-free Tetanus vaccine

Stablepharma Ltd, the Fridge-free Vaccine Company and BB-NCIPD Ltd (Bul Bio) European vaccine manufacturer, have signed a second agreement for the exclusive bulk supply and commercialisation of the Tetanus vaccine (SPVX06). This agreement follows a similar arrangement with Bul Bio for the Tetanus diphtheria vaccine (SPVX02) in September 2022. “As a result of this strategic […]

Read More
Lorena Carmona-Rodriguez

Lorena Carmona Rodriquez as Senior Scientist to specifically progress mRNA-LNP programme.

Stablepharma Ltd is delighted to announce that Lorena Carmona-Rodiguez is joining the Science Team at our R&D Centre in Madrid, Spain. Lorena joins ‘The Fridge-free Vaccine Company’ as Senior Scientist to specifically progress our mRNA-LNP programme. Lorena has a Master’s Degree and PhD in Molecular Biosciences from the Universidad Autónoma de Madrid. She was, until […]

Read More

Martin Powell RIP 1956 – 2023

It is with great sadness and regret that the Board of Stablepharma has to announce the unexpected passing of Martin Powell on the 1st of May 2023. As our colleague and fellow Director, Martin was someone who made substantial contributions to the company since the early days and we will all miss his company, enthusiasm […]

Read More